REQUEST A DEMO
Total
USD $0.00
Search more companies

Sunny Pharmtech Inc. (祥翊制药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sunny Pharmtech Inc. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Sunny Pharmtech Inc. is committed to the development of Oncology, Immuno-related) and other special drugs (Specialty Pharmaceuticals). The company was established in 2005, and headquartered in Taoyuan City, Taiwan.

Headquarters
No.255,Longyuan 1St Rd.,Longtan Dist
Taoyuan City; Taoyuan City;

Contact Details: Purchase the Sunny Pharmtech Inc. (祥翊制药股份有限公司) report to view the information.

Website: http://www.sunnypharmtech.com

Basic Information
Total Employees:
Purchase the Sunny Pharmtech Inc. (祥翊制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Sunny Pharmtech Inc. (祥翊制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Sunny Pharmtech Inc. (祥翊制药股份有限公司) report to view the information.
Incorporation Date:
February 03, 2005
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
9.77%
Purchase this report to view the information.
5.71%
Purchase this report to view the information.
1.65%
Purchase this report to view the information.
1.63%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sunny Pharmtech Inc. (祥翊制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-54.73%
Total operating revenue
-54.75%
Operating profit (EBIT)
-191.88%
EBITDA
N/A
Net Profit (Loss) for the Period
-288.91%
Total assets
-10.29%
Total equity
-23.01%
Operating Profit Margin (ROS)
-111.07%
Net Profit Margin
-127.7%
Return on Equity (ROE)
-13.7%
Debt to Equity Ratio
14.87%
Quick Ratio
-1.81%
Cash Ratio
-1.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?